Factory Supply Pharmaceutical Chemical Lidocaina HCl Powder CAS 73-78-9 Lidocaina

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: White Powder
• Purity: >96%
• Model NO.: HRK-Lidocaina
• Product Name: Lidocaina
• Appearance: White Crystalline Powder
• Certificate: GMP ISO USP Bp
• Test: HPLC
• CF: C14h23cln2o
• Sample: Lidocaina Avaliable
• Grade Standard: Medicine Grade
• Type of Product: Auxiliaries and Other Medicinal Chemicals
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Active Ingredient: Lidocaina Powder
• Color: White
• Place of Origin: Shaanxi, China
• Form: Powder
• CAS: 73-78-9
• Transport Package: 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
• Specification: 99% min Lidocaina
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 500000kg/Year

Product Description

   
               
Factory Supply Pharmaceutical Chemical Lidocaina HCl Powder CAS 73-78-9 Lidocaina
 

Product Name	Factory Supply Pharmaceutical Chemical Lidocaina HCl Powder CAS 73-78-9 Lidocaina
Color	Whitd Powder
Storage	Cool Dry Place
Shelf Life	2 Years Proper Storage

What is Lidocaina?

Lidocaine acts as a local anesthetic by reversibly blocking sodium channels and blocking the transmission of action potentials along nerve fibers. Sensory fibers are blocked earlier than motor fibers, so low doses of lidocaine can act as a selective sensory block. Lidocaine also has antiarrhythmic effects, belonging to class I and b antiarrhythmic drugs.

Function of lidocaine

Lidocaine is suitable for acute ventricular arrhythmias, including premature ventricular beats, ventricular tachycardia, and ventricular fibrillation, caused by acute myocardial infarction, surgery, digitalism, and cardiac catheterization. Secondly, it is also used for epileptic status.

Application of lidocaine

Lidocaine is the first-line agent for the treatment of ventricular arrhythmias caused by acute and severe hemodynamic abnormalities. It is also effective for some supraventricular arrhythmias, such as bypass mediated supraventricular tachycardia, and acute episodes or parasympathetic mediated cardioversion of atrial fibrillation. It is widely used for surface anesthesia of mucous membranes (e.g. before endotracheal intubation). EMLA cream is used to anesthetize the skin surface before intravenous catheterization. To ensure the anesthetic effect, apply it to the skin for 45 to 60 minutes, and wrap it with an airtight dressing to promote absorption. EMLA is very useful for ear vein catheterization in rabbits and for intravenous catheterization in young dogs and cats.